MINSK, 15 March (BelTA) – 2023 will be a year of breakthrough medicines in Belarus, Healthcare Minister Dmitry Pinevich told reporters prior to the final collegium of the Healthcare Ministry, BelTA has learned.
“When it comes to introduction of new medicines, we pin great hopes on our collaborations, in particular with partners from Russia. A number of contracts have been signed with China, including for the supply of substances. This will help cut costs and expand the range of medicines. We are working with Switzerland, with some partners from European countries. This year will be a year of a new portfolio of breakthrough medicines,” Dmitry Pinevich said.
The minister emphasized that Belarus managed to maintain stable operation of the domestic pharmaceutical market throughout 2022. “Moreover, the domestic pharmaceutical industry scaled up operations and we managed to respond to the pandemic-associated challenges. A number of new domestic medicines have been registered, which allows us to use new treatment methods,” he said.
However, increasing the output of medicines is not a goal in itself. It is more important to be able to replace critical imports, Dmitry Pinevich emphasized.
In addition to the achievements of the healthcare system, the board will discuss in detail problems and changes, in particular new approaches to personnel training and medical check-ups. “Many aspects of public health will come under close scrutiny,” the minister said.